Trial · NCT02251210
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of patients achieving 20% improvement assessed by the American College of Rheumatology (ACR) criteria (ACR20) | 3 months | |
| Secondary | Percentage of patients achieving 50% improvement (ACR50) | 3 months | |
| Secondary | Number of withdrawals due to lack of efficacy | up to 3 months | |
| Secondary | Number of swollen joints | up to 3 months | |
| Secondary | Number of tender joints | up to 3 months | |
| Secondary | Patient's assessment of pain on a visual analog scale (VAS) | up to 3 months | |
| Secondary | Patient's global assessment of disease activity by VAS | up to 3 months | |
| Secondary | Investigator's global assessment of disease activity by VAS | up to 3 months | |
| Secondary | Patient's assessment of physical function | up to 3 months | via Health Assessment Questionnaire (HAQ) |
| Secondary | Change in erythrocyte sedimentation rate (ESR) | up to 3 months | |
| Secondary | Change in C-reactive protein (CRP) | up to 3 months | |
| Secondary | Change in Quality of Life | baseline, 3 months | assessed by the SF-36 questionnaire |
| Secondary | Change in Disease Activity Score (DAS 28) | baseline, up to 3 months | Disease Activity Score in 28-joint count |
| Secondary | Change in duration of morning stiffness | up to 3 months | |
| Secondary | Consumption of rescue medication | up to 3 months | |
| Secondary | Number of patients with adverse events | up to 3 months | |
| Secondary | Number of withdrawals due to adverse events | up to 3 months | |
| Secondary | Final global assessment of tolerability by investigator on a 4-point scale | 3 months | |
| Secondary | Patient's assessment of fatigue by VAS | up to 3 months | |
| Secondary | Number of patients with clinically significant changes in laboratory findings | up to 3 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02251210/registered